Source document template - VA Portland

Specific additional criteria for standardized usage of prostate-specific antigen (PSA) and CA-125 response in support of clinical trials are being developed. Cytology, Histology These techniques can be used to differentiate between partial responses (PR) and complete responses (CR) in rare cases (e.g., residual lesions in tumor types, such as ... ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download